论文部分内容阅读
美国Ｇｅｎｅｔｅｃｈ Ｉｎｃ．公司最近在美国临床肿瘤学协会年会上宣布一项新的研究成果，该公司研究的抗癌新药Ｈｅｒｃｅｐｔｉｎ，有望为某些乳腺癌患者带来福音。Ｈｅｒｃｅｐｔｉｎ是一种人化的抗ＨＥＲ２Ｎ克隆抗体，它可以袭击ＨＥＲ２蛋白，这种蛋白能调节细胞生长?
Genetech Inc., USA The company recently announced a new study at the annual meeting of the American Society of Clinical Oncology. The company’s new anti-cancer drug Herceptin is expected to bring good news to some breast cancer patients. Herceptin is a humanized anti-HER2N monoclonal antibody that attacks the HER2 protein and regulates cell growth.